Committee Opinion No. 693 Summary: Counseling About Genetic Testing and Communication of Genetic Test Results
- PMID: 28333813
- DOI: 10.1097/AOG.0000000000002011
Committee Opinion No. 693 Summary: Counseling About Genetic Testing and Communication of Genetic Test Results
Abstract
Given the increasing availability and complexity of genetic testing, it is imperative that the practicing obstetrician-gynecologist or other health care provider has a firm comprehension of the benefits, limitations, and risks of offering a specific genetic test, as well as the importance of appropriate pretest and posttest counseling. The purpose of this Committee Opinion is to provide an outline of how obstetrician-gynecologists and other health care providers can best incorporate these tests into their current practices and provide appropriate pretest and posttest counseling to patients. Obstetrician-gynecologists and other health care providers should determine which tests will be offered as the standard in their practices so that similar testing strategies are made available to all patients. Practices should have procedures in place that ensure timely disclosure of test results to patients. As with any medical test, expectations regarding the performance of a genetic test should be discussed with the patient before the test is ordered. After counseling, patients should have the option to decline any or all testing. Pretest and posttest counseling should be done in a clear, objective, and nondirective fashion, which allows patients sufficient time to understand information and make informed decisions regarding testing and further evaluation or treatment. In addition to counseling each patient about her own personal risk, obstetrician-gynecologists and other health care providers should counsel patients regarding the risk for family members, including their potential to have affected offspring.
Similar articles
-
Committee Opinion No. 693: Counseling About Genetic Testing and Communication of Genetic Test Results.Obstet Gynecol. 2017 Apr;129(4):e96-e101. doi: 10.1097/AOG.0000000000002020. Obstet Gynecol. 2017. PMID: 28333821
-
American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.J Clin Oncol. 2003 Jun 15;21(12):2397-406. doi: 10.1200/JCO.2003.03.189. Epub 2003 Apr 11. J Clin Oncol. 2003. PMID: 12692171
-
ACOG Committee Opinion No. 727: Cascade Testing: Testing Women for Known Hereditary Genetic Mutations Associated With Cancer.Obstet Gynecol. 2018 Jan;131(1):e31-e34. doi: 10.1097/AOG.0000000000002457. Obstet Gynecol. 2018. PMID: 29266077 Review.
-
Genetic Counseling Overview for the Obstetrician-Gynecologist.Obstet Gynecol Clin North Am. 2018 Mar;45(1):1-12. doi: 10.1016/j.ogc.2017.10.008. Obstet Gynecol Clin North Am. 2018. PMID: 29428277 Review.
-
ACOG Committee Opinion No. 727 Summary: Cascade Testing: Testing Women For Known Hereditary Genetic Mutations Associated With Cancer.Obstet Gynecol. 2018 Jan;131(1):194-195. doi: 10.1097/AOG.0000000000002451. Obstet Gynecol. 2018. PMID: 29266071 Review.
Cited by
-
Rethinking the Burden of Traditional Informed Consent Prior to Prenatal Genetic Screening.Hastings Cent Rep. 2025 Mar;55(2):29-38. doi: 10.1002/hast.4976. Hastings Cent Rep. 2025. PMID: 40245273
-
Evaluating adherence to American College of Obstetricians and Gynecologists guidelines at the first obstetric visit.Womens Health (Lond). 2022 Jan-Dec;18:17455057221122590. doi: 10.1177/17455057221122590. Womens Health (Lond). 2022. PMID: 36173253 Free PMC article.
-
Executive Summary of the Early-Onset Breast Cancer Evidence Review Conference.Obstet Gynecol. 2020 Jun;135(6):1457-1478. doi: 10.1097/AOG.0000000000003889. Obstet Gynecol. 2020. PMID: 32459439 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials